Form 4: Nuvalent Director Matthew Shair Sells Shares Under 10b5-1 Trading Plan

Matthew Shair, a director at Nuvalent, Inc., executed multiple sales of Class A Common Stock on May 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 28, 2024, Matthew Shair, a director of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• A total of 1,999 shares were sold in multiple transactions at varying prices.
• Some shares were sold at a weighted average price ranging from $66.34 to $67.30.
• Other shares were sold at a weighted average price ranging from $67.34 to $68.31.
• The reporting person also directly owns 1,424,698 shares of Class A Common Stock.
• Following the reported transactions, the reporting person indirectly owns 234,522 shares through the Matthew D. Shair 2021 Irrevocable Family Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine stock sales by a company director under a pre-arranged trading plan. It doesn't inherently indicate positive or negative prospects for the company.

Industry Context

Sales by company insiders are a common occurrence and are often conducted under pre-arranged trading plans like Rule 10b5-1 to avoid accusations of insider trading. The market typically views these sales in the context of the overall holdings of the insider and the reasons behind the trading plan.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale relative to the director's holdings.

Key Dates